Mitomycin-C as a prototype bioreductive alkylating agent: In vitro studies of metabolism and cytotoxicity-Reference-Cited by-同舟云学术

Mitomycin-C as a prototype bioreductive alkylating agent: In vitro studies of metabolism and cytotoxicity

Published:1982-03 Issue:3-4 Volume:8 Page:753-755
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Rockwell Sara,Kennedy Katherine A.,Sartorelli Alan C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference11 articles.

1. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells;Kennedy;Cancer Res.,1980

2. Toxicity of Anthracyclines toward normally aerated and hypoxic tumor cells;Kennedy,1981

3. Kennedy, K.A., Sligar, S.G., Plomske, L., Sartorelli, A.C.: Metabolic activation of mitomycin C by liver microsomes and Nuclei. Biochem. Pharm. (In press).

4. Chemotherapeutic approaches to cell populations in tumors;Kennedy,1980

5. The hypoxic tumor cell: a target for selective cancer Fhemotherapy;Kennedy;Biochem. Pharm.,1980

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy;Frontiers in Pharmacology;2021-04-19

2. Clinical trials targeting hypoxia;The British Journal of Radiology;2018-07-06

3. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment;Cancer Letters;2016-09

4. Investigation into the hypoxia-dependent cytotoxicity of anticancer drugs under oxygen gradient in a microfluidic device;Microfluidics and Nanofluidics;2015-11-17

5. Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition;Pediatric Blood & Cancer;2015-03-02